ESMO responses to European Union and Global Public Consultations

The European Commission and the World Health Organization, among others, often seek the views and opinions of citizens and stakeholders through so-called public consultations when they develop policy and legislation.

The objective of public consultations is to provide external stakeholders and citizens an opportunity to provide input early in the decision-making process to express views on the scope, priorities and added value of new initiatives, or evaluations of existing policies and laws. The input of oncology experts in this process is crucial in order to represent the field of cancer, and help influence and shape legislation at EU and global levels. The results of public consultations guide the EU and WHO’s work throughout the policy cycle.

ESMO has submitted several responses to various consultations in order to express the needs and views of the oncology community on the areas European and global health authorities need to work on, which you can find below.

ESMO Responses

ESMO Responses

Artificial intelligence:

European Health Data Space:

EU rules on medicines for children and rare diseases:

Cross-border healthcare:

EU Pharmaceuticals Legislation:

European Medicines Agencies Network Strategy:

Pharmaceutical Strategy for Europe:

Europe’s Beating Cancer Plan:

Related Links